Clinical Trial: Very Early PCSK9 Inhibition for Acute Myocardial Infarction

U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07208006) titled 'Very Early PCSK9 Inhibition for Acute Myocardial Infarction' on Sept. 27.

Brief Summary: Acute myocardial infarction (AMI) remains a major cause of morbidity and mortality, particularly in patients with multivessel coronary artery disease. Although primary percutaneous coronary intervention (PCI) has significantly improved short-term outcomes, these patients remain at high risk of recurrent cardiovascular events due to vulnerable non-culprit plaques. Coronary imaging techniques such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), and angiography-derived indices (QFR, RWS) can identify high-risk lesions, but th...